The director of the National Institute of Biomedical Genomics in West Bengal's Kalyani, Dr Saumitra Das, spoke on the need for analysis on SARS-CoV-2 mutations, the crucial second phase of the study that will look at the impact of mutations on transmission and on the much-discussed D164G mutation.
from Top India News- News18.com https://ift.tt/3lnsDpY
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment